These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 18345967

  • 1. DNA-based vaccines: the future of multiple sclerosis therapy?
    Stüve O, Cravens PD, Eagar TN.
    Expert Rev Neurother; 2008 Mar; 8(3):351-60. PubMed ID: 18345967
    [Abstract] [Full Text] [Related]

  • 2. Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial.
    Bar-Or A, Vollmer T, Antel J, Arnold DL, Bodner CA, Campagnolo D, Gianettoni J, Jalili F, Kachuck N, Lapierre Y, Niino M, Oger J, Price M, Rhodes S, Robinson WH, Shi FD, Utz PJ, Valone F, Weiner L, Steinman L, Garren H.
    Arch Neurol; 2007 Oct; 64(10):1407-15. PubMed ID: 17698695
    [Abstract] [Full Text] [Related]

  • 3. Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
    Hermans G, Denzer U, Lohse A, Raus J, Stinissen P.
    J Autoimmun; 1999 Sep; 13(2):233-46. PubMed ID: 10479392
    [Abstract] [Full Text] [Related]

  • 4. BHT-3009, a myelin basic protein-encoding plasmid for the treatment of multiple sclerosis.
    Correale J, Fiol M.
    Curr Opin Mol Ther; 2009 Aug; 11(4):463-70. PubMed ID: 19649992
    [Abstract] [Full Text] [Related]

  • 5. Immunology of multiple sclerosis.
    Williams KC, Ulvestad E, Hickey WF.
    Clin Neurosci; 1994 Aug; 2(3-4):229-45. PubMed ID: 7749893
    [Abstract] [Full Text] [Related]

  • 6. Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis.
    Garren H, Robinson WH, Krasulová E, Havrdová E, Nadj C, Selmaj K, Losy J, Nadj I, Radue EW, Kidd BA, Gianettoni J, Tersini K, Utz PJ, Valone F, Steinman L, BHT-3009 Study Group.
    Ann Neurol; 2008 May; 63(5):611-20. PubMed ID: 18481290
    [Abstract] [Full Text] [Related]

  • 7. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
    Holmøy T.
    Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322
    [Abstract] [Full Text] [Related]

  • 8. DNA-based vaccines for multiple sclerosis: current status and future directions.
    Fissolo N, Montalban X, Comabella M.
    Clin Immunol; 2012 Jan; 142(1):76-83. PubMed ID: 21163708
    [Abstract] [Full Text] [Related]

  • 9. The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis.
    Hedegaard CJ, Krakauer M, Bendtzen K, Sørensen PS, Sellebjerg F, Nielsen CH.
    Clin Immunol; 2008 Oct; 129(1):80-9. PubMed ID: 18653385
    [Abstract] [Full Text] [Related]

  • 10. T-cell vaccination in multiple sclerosis.
    Achiron A, Mandel M.
    Autoimmun Rev; 2004 Jan; 3(1):25-32. PubMed ID: 14871646
    [Abstract] [Full Text] [Related]

  • 11. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE).
    Ziemssen T, Ziemssen F.
    Autoimmun Rev; 2005 Sep; 4(7):460-7. PubMed ID: 16137612
    [Abstract] [Full Text] [Related]

  • 12. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
    Zozulya AL, Wiendl H.
    Hum Immunol; 2008 Nov; 69(11):797-804. PubMed ID: 18723060
    [Abstract] [Full Text] [Related]

  • 13. [Immunologic multiple sclerosis research].
    Frick E.
    Wien Med Wochenschr; 1985 Jan 31; 135(1-2):8-9. PubMed ID: 2579511
    [Abstract] [Full Text] [Related]

  • 14. Th2 immune regulation induced by T cell vaccination in patients with multiple sclerosis.
    Zang YC, Hong J, Tejada-Simon MV, Li S, Rivera VM, Killian JM, Zhang JZ.
    Eur J Immunol; 2000 Mar 31; 30(3):908-13. PubMed ID: 10741408
    [Abstract] [Full Text] [Related]

  • 15. Oligoclonal bands and antibody responses in multiple sclerosis.
    Correale J, de los Milagros Bassani Molinas M.
    J Neurol; 2002 Apr 31; 249(4):375-89. PubMed ID: 11967640
    [Abstract] [Full Text] [Related]

  • 16. Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease.
    Raivich G, Banati R.
    Brain Res Brain Res Rev; 2004 Nov 31; 46(3):261-81. PubMed ID: 15571769
    [Abstract] [Full Text] [Related]

  • 17. [Infection and multiple sclerosis].
    Yamamura T.
    Rinsho Shinkeigaku; 1999 Jan 31; 39(1):24-5. PubMed ID: 10377791
    [Abstract] [Full Text] [Related]

  • 18. CD16+ gammadelta T cells mediate antibody dependent cellular cytotoxicity: potential mechanism in the pathogenesis of multiple sclerosis.
    Chen Z, Freedman MS.
    Clin Immunol; 2008 Aug 31; 128(2):219-27. PubMed ID: 18501678
    [Abstract] [Full Text] [Related]

  • 19. Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides.
    Fontoura P, Garren H, Steinman L.
    Int Rev Immunol; 2005 Aug 31; 24(5-6):415-46. PubMed ID: 16318989
    [Abstract] [Full Text] [Related]

  • 20. T-cell vaccination in multiple sclerosis: update on clinical application and mode of action.
    Hellings N, Raus J, Stinissen P.
    Autoimmun Rev; 2004 Jun 31; 3(4):267-75. PubMed ID: 15246022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.